
Kies je etiket
direct zichtbaar op de vial5-Amino + NAD+ (Oral)
Fat Loss
- Verzonden vanuit Duitsland
Bestelling
- DHL met tracking
- Discrete verpakking
In één oogopslag
5-Amino + NAD+ (Oral) in cijfers
De kerncijfers uit ons lexicon.
Volledig lexiconartikel- Type
- Oral blendNNMT inhibitor + NAD+ precursor
- Form
- Tablets100 mg per tab, 60 tabs
- Sizes
- 100 mg1 size in the shop
What studies show
All 5 sources in the lexicon- Nature (PubMed, PMID 24717514)
- Biochemical Pharmacology (PubMed, PMID 29155147)
- Biochemical Pharmacology (PubMed, PMID 30753815)
Er is nog geen labanalyse voor 5-Amino + NAD+ (Oral). Stem eropLaat het zelf testen, wij betalen de helftAlle labanalyses
Kennis
Alles over 5-Amino + NAD+ (Oral)
Uitgebreide informatie volgt binnenkort.
Are there studies on this blend?
No. ClinicalTrials.gov lists no trial with 5-Amino-1MQ and PubMed none on the combination with an NAD+ building block (as of 25 October 2026). Everything here comes from studies on the single building blocks.
How are the two building blocks meant to work together?
NNMT uses up nicotinamide (a precursor of NAD+) and the methyl donor SAM. When NNMT was inhibited, NAD+ and SAM rose in fat cells. The NAD+ building block additionally supplies precursors from outside. That both add up in humans is an assumption, not a proven effect.
What is shown in humans?
Only for an NAD+ precursor: in the NICE trial with 90 people with peripheral artery disease nicotinamide riboside improved the 6-minute walk over 6 months (plus 7.0 versus minus 10.6 metres on placebo). The entry does not name which precursor is in the blend. There are no human data on 5-Amino-1MQ.
What did the mouse studies on 5-Amino-1MQ show?
Obese mice lost 5.1 percent of their weight in 11 days, abdominal fat was about 35 percent lighter and cholesterol about 30 percent lower with the same food intake. In old mice grip strength rose by about 40 percent, with exercise by about 60 percent.
Does 5-Amino-1MQ work as a tablet?
That has not been tested. In the animal studies 5-Amino-1MQ was injected under the skin. Cell models of the gut wall showed that the compound passes membranes well, so the authors expect good absorption. A study with tablets in animals or humans is missing.
Which side effects are known?
There are no human data on the blend or on 5-Amino-1MQ. In the mouse study the authors saw no observable side effects. NNMT also occurs in the liver and other tissues, the consequences of long-term inhibition in humans are unknown.
Gerelateerd
Gerelateerde producten
AOD-9604
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
3 maten
= vanaf 13.2 €/vial
MOTS-C
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
4 maten
Laboratoriumgetest
= vanaf 16 €/vial
5-Amino-1MQ
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
4 maten
Laboratoriumgetest
= vanaf 10 €/vial
Adipotide
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
3 maten
= vanaf 18.8 €/vial
5-Amino + NAD+ (Oral)